Cargando…

Metaplastic breast cancer and BRCA1: first strong evidence of a link

Detalles Bibliográficos
Autores principales:	Evans, D. Gareth R, Howell, Anthony, Howell Sacha, J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2023
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10620387/ https://www.ncbi.nlm.nih.gov/pubmed/37592173 http://dx.doi.org/10.1038/s41431-023-01441-6

Ejemplares similares

Gene panel testing for breast cancer should not be used to confirm syndromic gene associations
por: Evans, D. Gareth, et al.
Publicado: (2018)

Are BRCA1- and BRCA2-related breast cancers associated with increased mortality?
por: Gareth Evans, D, et al.
Publicado: (2004)

Should unaffected female BRCA2 pathogenic variant carriers be told there is little or no advantage from risk reducing mastectomy?
por: Evans, D. Gareth, et al.
Publicado: (2019)

Risk of Contralateral Breast Cancer in Women with and without Pathogenic Variants in BRCA1, BRCA2, and TP53 Genes in Women with Very Early-Onset (<36 Years) Breast Cancer
por: Hyder, Zerin, et al.
Publicado: (2020)

Risks of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers
por: Ahmed, M, et al.
Publicado: (2010)

Gene Panel Testing for Breast Cancer Reveals Differential Effect of Prior BRCA1/2 Probability
por: Evans, D. Gareth, et al.
Publicado: (2021)

Penetrance estimates for BRCA1 and BRCA2 based on genetic testing in a Clinical Cancer Genetics service setting: Risks of breast/ovarian cancer quoted should reflect the cancer burden in the family
por: Evans, D Gareth, et al.
Publicado: (2008)

Young age at first pregnancy does protect against early onset breast cancer in BRCA1 and BRCA2 mutation carriers
por: Evans, DG, et al.
Publicado: (2017)

Contralateral breast cancer risk in BRCA1/2-positive families needs to be adjusted for phenocopy rates particularly in second-degree untested relatives
por: Evans, D Gareth R, et al.
Publicado: (2013)

Polygenic risk scores and breast cancer risk prediction
por: Roberts, Eleanor, et al.
Publicado: (2023)

Increased risk of breast cancer in neurofibromatosis type 1: current insights
por: Howell, Sacha J, et al.
Publicado: (2017)

Metaplastic carcinoma of the breast and BRCA1 germline mutation: a case report and review
por: Yamashita, Michiko, et al.
Publicado: (2021)

Breast cancer risk-assessment models
por: Evans, D Gareth R, et al.
Publicado: (2007)

Can multiple SNP testing in BRCA2 and BRCA1 female carriers be used to improve risk prediction models in conjunction with clinical assessment?
por: Prosperi, Mattia CF, et al.
Publicado: (2014)

Why the dual origins of high grade serous ovarian cancer matter
por: Colvin, Emily K., et al.
Publicado: (2020)

Choices for cancer prevention for women with a BRCA1 mutation? a personal view
por: Narod, Steven A.
Publicado: (2023)

Implementing Risk-Stratified Breast Screening in England: An Agenda Setting Meeting
por: McWilliams, Lorna, et al.
Publicado: (2022)

Effects of oestrogens and anti-oestrogens on normal breast tissue from women bearing BRCA1 and BRCA2 mutations
por: Bramley, M, et al.
Publicado: (2006)

Responding to COVID-19 requires strong epidemiological evidence of environmental and societal determining factors
por: Zeka, Ariana, et al.
Publicado: (2020)

NASA’s Europa Clipper—a mission to a potentially habitable ocean world
por: Howell, Samuel M., et al.
Publicado: (2020)

Extending research impact by sharing maker information
por: Howell, Larry L., et al.
Publicado: (2023)

Can the breast screening appointment be used to provide risk assessment and prevention advice?
por: Evans, D. Gareth, et al.
Publicado: (2015)

Sequencing technology status of BRCA1/2 testing in Latin American Countries
por: Solano, Angela R., et al.
Publicado: (2020)

Evaluating the Acceptance and Usability of an App Promoting Weight Gain Prevention and Healthy Behaviors Among Young Women With a Family History of Breast Cancer: Protocol for an Observational Study
por: Pegington, Mary, et al.
Publicado: (2022)

Correction: Evaluating the Acceptance and Usability of an App Promoting Weight Gain Prevention and Healthy Behaviors Among Young Women With a Family History of Breast Cancer: Protocol for an Observational Study
por: Pegington, Mary, et al.
Publicado: (2023)

Metaplastic Breast Cancer: To Radiate or Not to Radiate?
por: Tseng, Warren H., et al.
Publicado: (2010)

Treatment Options for Metaplastic Breast Cancer
por: Shah, Dhruvil R., et al.
Publicado: (2012)

Metaplastic breast cancer with chondroid differentiation
por: Myint, Zin W., et al.
Publicado: (2015)

Long-term outcomes of breast cancer in women aged 30 years or younger, based on family history, pathology and BRCA1/BRCA2/TP53 status
por: Evans, D G R, et al.
Publicado: (2010)

Emerging evidence linking the gut microbiome to neurologic disorders
por: Griffiths, Jessica A., et al.
Publicado: (2018)

Role of RPL39 in Metaplastic Breast Cancer
por: Dave, Bhuvanesh, et al.
Publicado: (2017)

Is Breast Cancer Risk Associated with Menopausal Hormone Therapy Modified by Current or Early Adulthood BMI or Age of First Pregnancy?
por: Leventea, Eleni, et al.
Publicado: (2021)

Parity and breast cancer risk among BRCA1 and BRCA2 mutation carriers
por: Antoniou, Antonis C, et al.
Publicado: (2006)

The importance of ethnicity: Are breast cancer polygenic risk scores ready for women who are not of White European origin?
por: Evans, D. Gareth, et al.
Publicado: (2021)

Does receiving high or low breast cancer risk estimates produce a reduction in subsequent breast cancer screening attendance? Cohort study
por: French, David P., et al.
Publicado: (2022)

Cell-free DNA sequencing sheds additional insights on BRCA-altered metastatic castration-resistant prostate cancer
por: Bazyar, Soha, et al.
Publicado: (2023)

Transcriptomic alterations underlying metaplasia into specific metaplastic components in metaplastic breast carcinoma
por: Lien, Huang-Chun, et al.
Publicado: (2023)

Metaplastic Breast Cancer in a Patient with Neurofibromatosis
por: Chaudhry, Umar Shafique, et al.
Publicado: (2015)

An Update on the Molecular Pathology of Metaplastic Breast Cancer
por: McCart Reed, Amy E, et al.
Publicado: (2021)

Metaplastic Breast Cancer: Characteristics and Survival Outcomes
por: Thapa, Bicky, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_mogpncnkvsp8va7dhrdnm2kgp9